drugset / Trial / NCT06046924

Dietary Acid Reduction and Progression of Chronic Kidney Disease

NCT06046924

Completed 153 enrolled Donald Wesson
RandomizedParallel-groupOpen-labelTreatment

Summary

Upon completion, this project will determine if dietary acid reduction done with either fruits and vegetables (F+V) or the medication sodium bicarbonate (NaHCO3) in study participants with high blood pressure (hypertension) and initially normal kidney function but with signs of kidney injury 1) slows progression of chronic kidney disease (CKD); 2) improves indices of cardiovascular risk; and 3) better preserves acid-base status. These studies are designed to determine if the simple and comparatively inexpensive intervention of dietary acid reduction can prevent or reduce adverse outcomes in individuals with early-stage CKD.

Timeline

Start
1996-06-24
Primary completion
2006-11-15
Completion
2011-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 650 mg Oral